STOCK TITAN

Kindred Biosciences to Present at the BofA Securities Animal Health Virtual Summit

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Kindred Biosciences (NASDAQ: KIN), a biopharmaceutical company dedicated to improving pet health, will present at the BofA Securities Animal Health Virtual Summit on February 25. CEO Dr. Richard Chin will deliver a presentation via webcast at 10:50 AM ET, followed by virtual one-on-one meetings with investors. The company aims to develop safe, effective biologics for pets based on successful human therapeutics. An archived version of the webcast will be available for 30 days on the KindredBio website.

Positive
  • None.
Negative
  • None.

SAN FRANCISCO, Feb. 16, 2021 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, will present at the BofA Securities Animal Health Virtual Summit on February 25.   

Dr. Richard Chin, Chief Executive Officer, will present via webcast at 10.50am ET and be available for virtual one-on-one meetings. During this time, investors will have the opportunity to discuss recent developments, study results from key therapeutic programs in development, and upcoming milestones.

An archived version of the above webcast will be available for 30 days on the KindredBio website.

About Kindred Biosciences 

Kindred Biosciences is a biopharmaceutical company developing innovative biologics focused on saving and improving the lives of pets. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The Company's strategy is to identify targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated targets for dogs and cats. KindredBio has a deep pipeline of novel biologics in development across many therapeutic classes, alongside state-of-the-art biologics manufacturing capabilities and a broad intellectual property portfolio.

For more information, visit: www.kindredbio.com

Contact
Katja Buhrer 
katja.buhrer@kindredbio.com 
(917) 969-3438

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/kindred-biosciences-to-present-at-the-bofa-securities-animal-health-virtual-summit-301229317.html

SOURCE Kindred Biosciences, Inc.

FAQ

When is Kindred Biosciences presenting at the BofA Securities Animal Health Virtual Summit?

Kindred Biosciences will present on February 25.

What time will Dr. Richard Chin's presentation start at the virtual summit?

Dr. Richard Chin's presentation will start at 10:50 AM ET.

How can investors participate in the Kindred Biosciences presentation?

Investors can join the presentation via webcast and schedule virtual one-on-one meetings.

Where can I find the archive of the Kindred Biosciences presentation?

The archived version of the presentation will be available on the KindredBio website for 30 days.

What is the main focus of Kindred Biosciences?

Kindred Biosciences focuses on developing biologics to improve the health of pets based on successful human medicines.

KIN

NASDAQ:KIN

KIN Rankings

KIN Latest News

KIN Stock Data

36.81M
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
Burlingame